Peck

emergency thoracic endovascular aortic repair (TEVAR) for a further rupture of descending thoracic aorta. All three ruptures were managed successfully and would usually be associated with near-certain death, only for the patient to succumb eventually to the complications of metastatic renal cell carcinoma.

Accumulating evidence indicates that…[Read more]

45 W/m·K at 773 K) was achieved due to the combined effect of rattling of Ba atoms in the voids and enhanced phonon scattering at the interfaces induced by nanosized InSb particles. As a result, the (InSb)0.15 + Ba0.3Co4Sb12 composite exhibited improved thermoelectric properties with the highest zT of 1.4 at 773 K and improved mechanical…[Read more]

Notably, in vivo administration of Juglone to human T-ALL xenotransplant models significantly reduced tumor growth, finally fostering the exploitation of Juglone-dependent Notch3 inhibition to perturb the ER stress/UPR signaling in Notch3-dependent T-ALL subsets.Transition-metal-carbonyl complexes are common organometallic reagents that feature…[Read more]

CSPG4-CAR.CIK also showed strong antitumor activity against STS spheroids; this effect was associated with tumor recruitment, infiltration, and matrix penetration. CSPG4-CAR.CIK significantly delayed or reversed tumor growth

in three STS xenograft models (leiomyosarcoma, undifferentiated pleomorphic sarcoma, and fibrosarcoma). Tumor growth…[Read more]

The future of survey research in the alcohol field, as elsewhere, does look gloomy. Even if there is a need to better confront this reality, abandoning traditional survey methods does not guarantee better outcomes and is not an equally burning issue in all countries or surveys and for all objectives. Correcting biases is easier when the aim is to…[Read more]

The long-term complication rates of open repair and thoracic endovascular aortic repair (TEVAR) have not yet been determined. Therefore, this study aimed to compare the long-term outcomes and aortic reintervention rates between open repair and TEVAR in patients with descending thoracic aortic pathologies.

Between January 2002 and December…[Read more]

PACAP or NRG-1 increased the proliferation of NSCLC cells, whereas PACAP(6-38), gefitinib, trastuzumab, or mAb3481 inhibited proliferation. The results indicate that PAC1 regulates the proliferation of NSCLC cells as a result of transactivation of the EGFR, HER2, and HER3.Astrocyte activation is characterized by hypertrophy with increased glial…[Read more]